US Patent Issued to The Feinstein Institutes for Medical Research on July 7 for "Treatment of inflammation by selective DMV cholinergic neuron stimulation" (New York, Connecticut Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,205, issued on July 7, was assigned to The Feinstein Institutes for Medical Research (Manhasset, N.Y.).

"Treatment of inflammation by selective DMV cholinergic neuron stimulation" was invented by Adam M. Kressel (Plainview, N.Y.), Valentin A. Pavlov (Bayside, N.Y.), Sangeeta S. Chavan (Syosset, N.Y.) and Kevin J. Tracey (Old Greenwich, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for electrical modulation of inflammation or serum TNF levels in a subject."

The patent was filed on Sept. 27, 2023, under Application No. 18/373,673.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacg...